Archives of Pharmacal Research

  • 제24권4호
  • /
  • Pages.338-341
  • /
  • 2001
  • /
  • 0253-6269(pISSN)
  • /
  • 1976-3786(eISSN)
대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

Circadian Changes in Pharmacokinetics of Sulfamethoxazole Administered Orally to Rabbits

  • 발행 : 2001.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Circadian variations of sulfamethoxazole pharmacokinetics were studied after a single oral administration of sulfamethoxazole, 50 mg/kg, to rabbits at 09:00 (a.m.) and 22 :00 (p.m.). The profiles of plasma sulfamethoxazole concentration showed from 6h to 24 h significant statistical difference (p<0.05) between 09:00 and 22:00. The half-life $t_{1/2} was significantly shorter in the morning (11.2 $\pm$3.2 h) when compared to the nighttime (15.4 $\pm$ 3.5h) (7< 0.05). The AUC was significantly decreased in the morning (1325 $\pm$ 264${u}g/ml$.h) than that in the nighttime (2059 $\pm$ 379${u}g/ml$. h) (p<0.05). Tota1 body clearance ($Cl_t$ was significantly higher when sulfamethoxazole was given in the morning (6.65 $\pm$ 0.23 ml/min) versus in the nighttime (4.28 $\pm$ 0.20 ml/min) (p<0.05).

키워드

참고문헌

  1. Life Sci. v.52 Recent advances in chronopharmacokinetics: methodological problem Bruguerolle,B.
  2. Kor. J. Clin.Pharm. v.2 Chronopharmacokinetics of vancomycin in normal volunteers Choi,J.S.;You,J.S.;Burm,J.P.;Choi,B.C.
  3. Res. Commun. Mol. Pathol. and Pharmacol. v.103 Circadian changes in pharmacokinetics of cyclosporin in healthy volunteers Choi,J.S.;Park,H.J.
  4. Chlonobiology International v.16 Administration-time differences in the pharmacokinetics of gentamycin intravenously delivered to human beings Choi,J.S.;Kim,C.K.;Lee,B.J.
  5. J. Pharm. Sci. v.67 Critical evaluation of potential error in pharmacokinetic studies using the liner trapezoidal rule method for calculation of the area under the plasma level-time curve Chiou,W.L.
  6. Eur. J. Clin. Pharmacol. v.20 Circadian changes in the bioavailability and effect of indomethacin in healthy subject Clench,J.;Reinberg,A.;Dziewanowska,Z.
  7. J. Pharmacokinet. Biopharm. v.5 Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects Eatman,F.B.;Colburn,W.A.;Boxenbaum,H.G.;Posmanter,H.N.;Weinfeld,R.E.;Ronfeld,R.;Weissman,L.;Moore,J.D.;Gibaldi,M.;Kalpan,S.A.
  8. Clin. Oncol. v.21 Cis-diamine-dichloroplatinium(DDP) toxicity to the human kidney reduced by circadian timing Hrusheky,W.;Levi,F.;Kennedy,B.J.
  9. Clin. Pharmacol. Ther. v.32 Circadian time dependence in cisplastin urinary kinetics Hrushesky,W.J.M.;Borch,R.;Levi,F.
  10. J. Pharmacokinet. Biopharm. v.21 Pharmacokinetics and pharmacidynamics of furosemide in protein-calorie malnutration Kim,S.H.;Choi,Y.M.;Lee,M.G.
  11. Clin. Pharmacol. Ther. v.32 Physiologic and temporal variation in hepatic elimination of midazolam Klotz,U.;Ziegler,G.
  12. In recent advances in the chronobiology of allergy and immnology Kyle,G.M.;Smolensky,K.;Korczynska,J.;Mcgoven,J.P.;Smolensky,M.H.(ed.)
  13. Clin. Pharmacokinet. v.7 Diurnal variations in steady-state plasma concentration of valproic acid in epiletic patients Loiseau,P.;Cenraud,B.;Levy,R.H.;Akbaraly,R.
  14. Nulfonamides, trimethoprim-sulfamethoxazole, quinidines, and agents for urinary treat infestions,in Goodman&Gilmans The Pharmacological Basis of Therapeutics (Ninth edition) Mandel,G.L.;Petri,W.A.Jr.;Hardman,J.G.(ed.);Limbird,L.E.(ed.);Molinoff,P.B.(ed.);Ruddon,R.W.(ed.);Gilman,A.G.(ed.)
  15. In recent advances in the chronobiology of allergy and immunology Markiewicz,A.;Semenowicz,K.;Korczynska,J.;Boldys,H.;Smolensky,M.H.(ed.)
  16. J. Clin. Pharmacol. Biopharm. v.32 Time dependent changes in the pharmacokinetics of aspirin Markiewicz,A.;Semenowicz,K.
  17. Rev. Can. Biol. v.32 no.Suppl. The effect of food intake and sleep on absorption of acetaminophen Mattok,G.L.;Mcgilveray,J.
  18. Eur. J. Clin. Pharmacol. v.29 Pharmacokinetics of triamcinolone acetonide and its phosphate ester Mollmann,H.;Rohdewald,P.;Schmidt,E.W.;Salomom,V.;Derendorf,H.
  19. Clin. Pharmacol. Ther. v.23 No circadian effect on nortriptyline kinetics in man Nakano,S.;Hollister,I.E.
  20. J. Pharmacol. Exp.Ther. v.163 Daily rhythmic variation in hepatic drug metabolism in rat and mouse Radzialowski,F.;Bousquet,W.
  21. Clin. Pharmacokinet. v.7 Circadian changes of drug disposition in man Reignberg,A.;Smolensky,M.
  22. Clin. Pharmacol. Ther. v.22 Temporal variation of antipyrine half-life in man Vessel,E.S.;Shively,C.A.;Passananti,G.T.
  23. Clin.Pharmacokinet. v.4 Pharmacokinetics of N¹-acetyl-and N⁴-acetylsulfamethoxazole in man Vree,T.B.;Hekster,Y.A.;Orelly,W.J.
  24. Ther. Drug Monitor. v.3 Renal excretion of sulfamethoxazole and its metabolite N⁴-acetylsulphamethoxazole in patients with impaired kidney function Vree,T.B.;Heketer,Y.A.;Van Dalen,R.;Friesen,W.T.
  25. J. Chromatogr. v.B.658 Determination of sulfamethoxazole and metabolites in human plasma and urine by HPLC Vree,T.B.;Vander,A.J.;Van Galen,P.M.